3//SEC Filing
COLUMN GROUP II, LP 3
Accession 0001209191-20-025500
CIK 0001796280other
Filed
Apr 22, 8:00 PM ET
Accepted
Apr 23, 8:43 PM ET
Size
11.8 KB
Accession
0001209191-20-025500
Insider Transaction Report
Form 3
COLUMN GROUP II, LP
10% Owner
Holdings
- 75,000
Common Stock
Series B Preferred Stock
→ Common Stock (625,000 underlying)Series A Preferred Stock
→ Common Stock (3,500,000 underlying)Series C Preferred Stock
→ Common Stock (416,666 underlying)Series D Preferred Stock
→ Common Stock (151,515 underlying)
Column Group II GP, LP
10% OwnerOther
Holdings
Series C Preferred Stock
→ Common Stock (416,666 underlying)Series A Preferred Stock
→ Common Stock (3,500,000 underlying)Series D Preferred Stock
→ Common Stock (151,515 underlying)- 75,000
Common Stock
Series B Preferred Stock
→ Common Stock (625,000 underlying)
GOEDDEL DAVID V
10% OwnerOther
Holdings
Series B Preferred Stock
→ Common Stock (625,000 underlying)Series D Preferred Stock
→ Common Stock (151,515 underlying)- 75,000
Common Stock
Series A Preferred Stock
→ Common Stock (3,500,000 underlying)Series C Preferred Stock
→ Common Stock (416,666 underlying)
Footnotes (2)
- [F1]The securities are directly held by The Column Group II, LP ("TCG II LP"), and indirectly held by The Column Group II GP, LP ("TCG II GP"), the general partner of TCG II LP. The managing partners of TCG II GP are David Goeddel and Peter Svennilson. The managing partners of TCG II GP may be deemed to have voting and investment power with respect to such shares. TCG II GP and each individual managing partner disclaims beneficial ownership of these shares, except to the extent of their respective pecuniary interest in such shares.
- [F2]The number of shares of Common Stock reflects a 1-for-4 reverse stock split of the Issuer's Common Stock and Preferred Stock which became effective April 21, 2020. Each of the Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock and Series D Preferred Stock shall automatically convert into shares of Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common Stock, for no additional consideration, and has no expiration date.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001600420
Filing Metadata
- Form type
- 3
- Filed
- Apr 22, 8:00 PM ET
- Accepted
- Apr 23, 8:43 PM ET
- Size
- 11.8 KB